Chin Augmentation Injections
A Permanent Solution for Removal of Double Chin Fat
Bye-bye double chin. No surgery. No kidding!
For a lot of people – men and women alike, the appearance of a double chin - whether it is caused by ageing, genetics or weight changes, is a sensitive issue and it is the first thing they see when they look in the mirror!
Dr Roos has recently returned from the Australian launch of a new TGA Approved injectable product (Deoxycholic Acid), which is designed to improve the appearance of your double chin, resulting in a more contoured neck profile and jawline. This non-surgical procedure will be customised to suit the anatomy and circumstances of each individual patient, ensuring a safe and effective treatment every time.
The immediate benefit of this treatment, being non-surgical, is that no anaesthesia is required, there is no wound to tend to, no scarring, and little social downtime. The injections can cause redness, swelling, tingling, minor bruising and hardness in the area treated, but these symptoms resolve naturally within a few days.
This injectable product is a synthetic version of the naturally occurring molecule, deoxycholic acid, which is produced naturally in our intestines to break down and absorb dietary fats. When injected into the subcutaneous fat under the chin, the membranes of the targeted fat cells breakdown and are destroyed. Once eliminated the dead cells are removed through the bodies normal excretion process.
Progression is slow but steady, taking four to six weeks post treatment to realise the full effect. Multiple treatments may be necessary depending on desired results of individuals. Once this is achieved, further treatment is not expected.
To find out more about this exciting new treatment, CoolSculpting body contouring, and all the other non-invasive cosmetic treatments that Cosmetic Elegance Clinic has to offer, please read through our website or call us on 4638 2700.
I INHERITED MY DOUBLE CHIN FROM MY FAMILY. I WAS SO FRUSTRATED BECAUSE IT FELT OUT OF MY CONTROL.